Metabolic syndrome (MetS) is considered as an insulin resistant syndrome comprising impaired glucose tolerance, decreased insulin sensitivity, dyslipidemia, central obesity, and hypertension, all of which are well- established risk factors for CVDs [4]. Here, INS is linked to metabolic syndrome.